Medical Research Clinical Trials Epidemiology Drug Development Pharmacology Oncology Pharmacology Immunology Clinical Trials Risk Assessment
Researchers identify ten cerebrospinal fluid metabolites and β-oxidation abnormalities as key predictors of fatal outcomes, paving the way for targeted therapies.